Acta Naturae

Papers
(The median citation count of Acta Naturae is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Parkinson’s Disease Associated with GBA Gene Mutations: Molecular Aspects and Potential Treatment Approaches28
Photoluminescent Nanomaterials for Medical Biotechnology24
Chromatin Modifiers in Transcriptional Regulation: New Findings and Prospects23
The p53 Protein Family in the Response of Tumor Cells to Ionizing Radiation: Problem Development19
Super-Enhancers in the Regulation of Gene Transcription: General Aspects and Antitumor Targets18
Peculiarities of the Presentation of the Encephalitogenic MBP Peptide by HLA-DR Complexes Providing Protection and Predisposition to Multiple Sclerosis12
Review of the textbook "Immunology" (2021, author - Academician of the Russian Academy of Sciences R. M. Khaitov)11
Neutrophil Extracellular Traps (NETs): Opportunities for Targeted Therapy10
The Role of Non-coding RNAs in the Pathogenesis of Glial Tumors10
Poly(ADP-Ribosyl) Code Functions9
Molecular Mechanisms of Muscle Tone Impairment under Conditions of Real and Simulated Space Flight9
Hybrid Complexes of Photosensitizers with Luminescent Nanoparticles: Design of the Structure9
Snail-Family Proteins: Role in Carcinogenesis and Prospects for Antitumor Therapy9
Voltage-Sensing Domain of the Third Repeat of Human Skeletal Muscle NaV1.4 Channel As a New Target for Spider Gating Modifier Toxins8
MicroRNAs in the Myelodysplastic Syndrome7
Genetic Diversity and Evolution of the Biological Features of the Pandemic SARS-CoV-27
Cardiovascular Effects of Snake Toxins: Cardiotoxicity and Cardioprotection6
Efficacy of (R)-6-Adamantane-Derivatives of 1,3-Oxazinan-2-One and Piperidine-2,4-Dione in The Treatment of Mice Infected by the A/California/04/2009 influenza Virus6
Method for assessment of nucleotide excision repair system efficiency <i>ex vivo</i>5
Molecular Tools for Targeted Control of Nerve Cell Electrical Activity. Part I5
0.025570154190063